Value Line® Target 25 Portfolio, 2nd Quarter 2023 Series
The Strategy
This unit investment trust invests in a fixed portfolio
of stocks for approximately 15 months. The stocks are
selected by applying a disciplined investment strategy
which adheres to pre-determined factors.
The strategy is based on these steps:
- We begin with the 100 stocks that Value Line® currently
gives a #1 ranking for TimelinessTM (stocks of financial
companies, limited partnerships and companies whose
shares are not listed on a U.S. exchange are not eligible for
inclusion in the Value Line® Target 25 Strategy). Value
Line® ranks approximately 1,700 stocks, only 100 of which
are given their #1 ranking for TimelinessTM. They base their
rankings on a long-term trend of earnings, prices, recent
earnings, price momentum, and earnings surprises.
- We then rank the Value Line® #1 stocks for TimelinessTM
based on their 12-month and 6-month price appreciation, return on assets,
and price to cash flow.
- The 25 eligible stocks with the best overall ranking on
the four factors are selected by the sponsor for the
portfolio. The stocks are weighted by market
capitalization subject to a minimum weighting of
approximately 1% and a maximum weighting of
approximately 25%.
If this strategy had been applied since 1985, investors
would have realized higher total returns than by investing
in the S&P 500 Index. It is important to note that the past
performance of the strategy is hypothetical and it is not
indicative of the future performance of the Value Line®
Target 25 Portfolio. Although this unit investment trust
terminates in approximately 15 months, the strategy is
long-term. Investors should consider their ability to
pursue investing in successive portfolios, if available.
There may be tax consequences unless units are
purchased in an IRA or other qualified plan.
Portfolio Objective
This unit investment trust seeks above-average total return;
however, there is no assurance the objective will be met.
Not FDIC Insured Not Bank Guaranteed May Lose Value |

Standard Deviations* |
Average Annual Total Returns* |
|
S&P 500 Index |
Strategy |
S&P 500 Index |
Strategy |
Since 1985 |
15.33% |
24.47% |
11.07% |
14.01% |
25 years |
15.67% |
24.03% |
7.63% |
8.20% |
20 years |
14.75% |
20.18% |
9.79% |
4.93% |
15 years |
16.31% |
21.19% |
8.79% |
0.25% |
10 years |
14.76% |
17.66% |
12.54% |
7.19% |
5 years |
18.68% |
22.19% |
9.41% |
5.85% |
3 years |
21.15% |
26.23% |
7.65% |
8.43% |
*Through 12/31/22 |
Annual Total Returns |
Year |
S&P 500 Index |
Strategy |
1985 |
31.72% |
33.25% |
1986 |
18.67% |
20.16% |
1987 |
5.25% |
16.87% |
1988 |
16.56% |
-9.45% |
1989 |
31.62% |
48.10% |
1990 |
-3.19% |
3.08% |
1991 |
30.33% |
83.68% |
1992 |
7.61% |
-2.69% |
1993 |
10.04% |
24.98% |
1994 |
1.30% |
12.10% |
1995 |
37.50% |
52.09% |
1996 |
22.89% |
54.12% |
1997 |
33.31% |
33.81% |
1998 |
28.55% |
90.93% |
1999 |
21.03% |
111.14% |
2000 |
-9.10% |
-10.43% |
2001 |
-11.88% |
-0.17% |
2002 |
-22.09% |
-23.95% |
2003 |
28.65% |
39.23% |
2004 |
10.87% |
21.72% |
2005 |
4.90% |
19.64% |
2006 |
15.76% |
0.63% |
2007 |
5.56% |
23.49% |
2008 |
-36.99% |
-51.45% |
2009 |
26.46% |
3.07% |
2010 |
15.08% |
28.53% |
2011 |
2.08% |
-29.31% |
2012 |
15.98% |
14.14% |
2013 |
32.36% |
33.91% |
2014 |
13.66% |
9.90% |
2015 |
1.38% |
-9.48% |
2016 |
11.93% |
5.27% |
2017 |
21.80% |
7.46% |
2018 |
-4.39% |
-4.05% |
2019 |
31.45% |
8.61% |
2020 |
18.39% |
37.22% |
2021 |
28.67% |
41.48% |
2022 |
-18.12% |
-34.33% |
2/28/23 |
3.68% |
-1.87% |
Past performance is no guarantee of future results and the actual current
performance of the portfolio may be lower or higher than the hypothetical performance
of the strategy. Hypothetical returns for the strategy in certain years were
significantly higher than the returns of the S&P 500 Index. Hypothetical strategy
returns were the result of certain market factors and events which may not be
replicated in the future. You can obtain performance information which is current
through the most recent month-end by calling First Trust Portfolios L.P. at
1-800-621-1675 option 2. Investment return and principal value of the portfolio
will fluctuate causing units of the portfolio, when redeemed, to be worth more
or less than their original cost.
Simulated strategy returns are hypothetical, meaning that they do not
represent actual trading, and, thus, may not reflect material economic
and market factors, such as liquidity constraints, that may have had an
impact on actual decision making. The hypothetical performance is the
retroactive application of the strategy designed with the full benefit of
hindsight. Strategy returns reflect a sales charge of 1.85% in the first year
and estimated annual operating expenses of 0.172%, plus organization
costs, but not taxes or commissions paid by the portfolio to purchase
securities. Returns assume that all dividends received during a year are
reinvested monthly. Actual portfolio performance will vary from that of
investing in the strategy stocks because it may not be weighted the same
as the strategy stocks and may not be fully invested at all times. It is
important to note that the strategy may underperform the S&P 500 Index
in certain years and may produce negative results.
The S&P 500 Index is an unmanaged index of 500 stocks used to measure large-cap
U.S. stock market performance. The index cannot be purchased directly by investors.
Standard Deviation is a measure of price variability (risk). A higher degree of variability indicates more volatility and therefore greater risk.
You should consider the portfolio's investment objectives, risks, and
charges and expenses carefully before investing. Contact your financial professional
or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Risk Considerations
An investment in this unmanaged unit investment trust should be made
with an understanding of the risks involved with owning common stocks, such as an economic recession and
the possible deterioration of either the financial condition of the issuers of the equity securities or the general
condition of the stock market. In addition, the portfolio is heavily weighted in only a few stocks, making it
more volatile than an equally weighted portfolio.
You should be aware that the portfolio is concentrated in stocks in the health care sector which involves
additional risks, including limited diversification. The companies engaged in the health care sector are
subject to fierce competition, high research and development costs, governmental regulations, loss of patent
protection, and changing consumer spending trends. In addition, health crises, such as a pandemic outbreak,
can severely impact the health care industry in particular.
Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers.
An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as
the share prices of small-cap companies and certain mid-cap companies are often more volatile than those
of larger companies due to several factors, including limited trading volumes, products, financial resources,
management inexperience and less publicly available information.
Large capitalization companies may grow at a slower rate than the overall market.
As the use of Internet technology has become more prevalent in the course of business, the trust
has become more susceptible to potential operational risks through breaches in cybersecurity.
In February 2022, Russia invaded Ukraine which has caused and could continue to cause significant market disruptions and volatility within the markets in Russia, Europe, and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.
The COVID-19 global pandemic and the ensuing policies enacted by governments and central banks have caused and may continue to cause significant volatility and uncertainty in global financial markets. While the U.S. has resumed “reasonably” normal business activity, many countries continue to impose lockdown measures. Additionally, there is no guarantee that vaccines will be effective against emerging variants of the disease.
The value of the securities held by the trust may be subject to steep declines or increased volatility
due to changes in performance or perception of the issuers.
“Value Line”, “The Value Line Investment Survey”, and “Timeliness,” are trademarks or registered trademarks of Value Line, Inc. (“Value Line”)
and have been licensed for use for certain purposes by First Trust Portfolios L.P. This product is not sponsored, endorsed, recommended, sold or
promoted by Value Line and Value Line makes no representation regarding the advisability of investing in products utilizing such strategy. First
Trust Portfolios L.P. is not affiliated with any Value Line company.